Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UNKL antisense RNA 1 (UNKL-AS1)
- Target
- UNKL-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other (noncoding RNA)
01
Overview
UNKL antisense RNA 1 (UNKL-AS1) is a long non-coding RNA transcribed in the antisense direction from the UNKL gene locus. Like other antisense lncRNAs, it may be involved in modulating the expression of its sense gene through chromatin remodeling, transcriptional interference, or interaction with RNA-binding proteins. There is currently no direct evidence connecting UNKL-AS1 to specific biological functions, disease states, nor as a therapeutic target. Antisense lncRNAs in general play important roles in gene regulation and epigenetics, and some have been implicated in human cancers via regulation of neighboring sense genes. However, the evidence for a direct disease role, actionable drug interaction, or utility for UNKL-AS1 is lacking in the available literature.
- Other names
- UNKL-AS1LA16c-312E8.2
02
Biological functions
Regulation of gene expressionChromatin modificationTranscriptional regulation
03
Disease associations
Other (no explicit disease linkage for UNKL-AS1 found; generally, antisense lncRNAs may be implicated in cancer and epigenetic regulation, but no direct evidence for UNKL-AS1)
04
Safety considerations
General challenges exist in targeting lncRNAs due to off-target effects and delivery
Beyond the preview
Go deeper on UNKL antisense RNA 1 (UNKL-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UNKL antisense RNA 1 (UNKL-AS1).